Published in J Nutr Health Aging on April 01, 2010
Measures of frailty in population-based studies: an overview. BMC Geriatr (2013) 1.69
Screening for frailty in primary care: a systematic review of the psychometric properties of the frailty index in community-dwelling older people. BMC Geriatr (2014) 0.89
The Frailty Instrument for primary care of the Survey of Health, Ageing and Retirement in Europe predicts mortality similarly to a frailty index based on comprehensive geriatric assessment. Geriatr Gerontol Int (2012) 0.82
Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (1997) 9.09
Hydrogen bonding in globular proteins. Prog Biophys Mol Biol (1984) 6.58
Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature (1990) 6.41
A reevaluation of the duration of survival after the onset of dementia. N Engl J Med (2001) 4.86
Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol (2001) 4.56
Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal (2001) 4.47
Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet (1997) 4.39
A phenomenology of scut. Ann Intern Med (1991) 3.46
The structure of 2Zn pig insulin crystals at 1.5 A resolution. Philos Trans R Soc Lond B Biol Sci (1988) 3.30
A brief clinical instrument to classify frailty in elderly people. Lancet (1999) 3.27
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? Int J Geriatr Psychiatry (2001) 3.09
Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry (1999) 3.07
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J (1999) 2.81
Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl (2000) 2.56
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Income and the midlife peak in common mental disorder prevalence. Psychol Med (2010) 2.13
Structural insights into the mode of action of a pure antiestrogen. Structure (2001) 1.92
Aging, frailty and age-related diseases. Biogerontology (2010) 1.81
Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry (1998) 1.71
Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology (2001) 1.64
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: implications for physicians. CMAJ (1996) 1.57
The prevalence of cognitive impairment in an elderly Canadian population. Acta Psychiatr Scand (1989) 1.48
Locating interaction sites on proteins: the crystal structure of thermolysin soaked in 2% to 100% isopropanol. Proteins (1999) 1.46
Illness presentation in elderly patients. Arch Intern Med (1995) 1.43
Behavioral problems in nursing home residents. Safe ways to manage dementia. Postgrad Med (1995) 1.38
Incidence of aflatoxins in Iran pistachio nuts. Food Chem Toxicol (2006) 1.38
Experimental and computational mapping of the binding surface of a crystalline protein. Protein Eng (2001) 1.35
Vascular dementia : incidence and risk factors in the Canadian study of health and aging. Stroke (2000) 1.35
Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine. J Mol Biol (1999) 1.32
Multidimensionality in instrumental and basic activities of daily living. J Clin Epidemiol (1998) 1.32
Structure and function of endoglucanase V. Nature (1993) 1.31
Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology (2001) 1.31
The x-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 angstrom resolution. Nat Struct Biol (1996) 1.27
Understanding the mechanism of ice binding by type III antifreeze proteins. J Mol Biol (2001) 1.22
Effect of smoking on the accumulation of deficits, frailty and survival in older adults: a secondary analysis from the Canadian Study of Health and Aging. J Nutr Health Aging (2009) 1.22
Testing the measurement properties of the Short Form-36 Health Survey in a frail elderly population. J Clin Epidemiol (1998) 1.21
Physical activity and dementia risk in the elderly: findings from a prospective Italian study. Neurology (2007) 1.20
Frailty in relation to the risk of falls, fractures, and mortality in older Chinese adults: results from the Beijing Longitudinal Study of Aging. J Nutr Health Aging (2012) 1.17
The use of goal attainment scaling in a geriatric care setting. J Am Geriatr Soc (1992) 1.17
HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site. Proteins (1994) 1.17
Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiology (1996) 1.15
Rasch analysis of the hierarchical assessment of balance and mobility (HABAM). J Clin Epidemiol (2000) 1.14
The Canadian Study of Health and Aging: risk factors for vascular dementia. Stroke (1997) 1.13
Automated method for modeling seven-helix transmembrane receptors from experimental data. Biophys J (1995) 1.12
Blood micronutrient and thyroid hormone concentrations in the oldest-old. J Clin Endocrinol Metab (2000) 1.12
Transitions in cognitive status in relation to frailty in older adults: a comparison of three frailty measures. J Nutr Health Aging (2011) 1.09
Analysis of C alpha geometry in protein structures. Proteins (1994) 1.08
Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds. J Chem Inf Comput Sci (2004) 1.07
Ligand-induced conformational change in penicillin acylase. J Mol Biol (1998) 1.07
Structure and mechanism of the oestrogen receptor. Biochem Soc Trans (2003) 1.07
Goal attainment scaling as a measure of clinically important change in nursing-home patients. Age Ageing (1999) 1.05
A Hierarchical Assessment of Balance and Mobility. Age Ageing (1995) 1.05
Incidence and etiology of dementia in a large elderly Italian population. Neurology (2005) 1.03
4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia. Can J Neurol Sci (2012) 1.03
A structural biologist's view of the oestrogen receptor. J Steroid Biochem Mol Biol (2000) 1.02
Serum concentrations of zinc and selenium in elderly people: results in healthy nonagenarians/centenarians. Exp Gerontol (2001) 1.02
Comparison of the prognostic importance of diagnosed diabetes, co-morbidity and frailty in older people. Diabet Med (2010) 1.01
A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology (2003) 1.01
Reliability and validity of questions about exercise in the Canadian Study of Health and Aging. Int Psychogeriatr (2001) 1.01
The association between parkinsonism, Alzheimer's disease, and mortality: a comprehensive approach. J Am Geriatr Soc (2000) 1.00
Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged >/=90 y. Am J Clin Nutr (2000) 1.00
Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution? Ann N Y Acad Sci (2000) 1.00
Vitamin D, thyroid hormones and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians. Clin Exp Immunol (1999) 0.99
Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects. J Nutr Health Aging (2000) 0.99
Frailty in older inpatients: what physicians need to know. QJM (2012) 0.99
The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. J Clin Endocrinol Metab (1996) 0.99
Insulin's structural behavior and its relation to activity. Biopolymers (1983) 0.99
Measurement of body fat in healthy elderly men: a comparison of methods. J Gerontol A Biol Sci Med Sci (1999) 0.99
Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients. Int Psychogeriatr (1998) 0.99
Molecular structure of insulin: the insulin monomer and its assembly. Br Med Bull (1989) 0.98
Incidence and risk factors for delirium and other adverse outcomes in older adults after coronary artery bypass graft surgery. Can J Cardiol (1999) 0.97
Outcomes of coronary artery bypass surgery in elderly people. Can J Cardiol (1998) 0.97
The rate of decline in function in Alzheimer's disease and other dementias. J Gerontol A Biol Sci Med Sci (1999) 0.96
Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment (MCI). Arch Gerontol Geriatr (2007) 0.96
An individualized approach to outcome measurement in geriatric rehabilitation. J Gerontol A Biol Sci Med Sci (1999) 0.95
Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment. Neurol Res (2006) 0.95
Validity of the confusion assessment method in detecting postoperative delirium in the elderly. Int Psychogeriatr (1999) 0.95
Prevalence and severity of dementia among northern Italian centenarians. Neurology (1999) 0.94
Trajectories of changes over twelve years in the health status of Canadians from late middle age. Exp Gerontol (2012) 0.94
Relating structure to thermodynamics: the crystal structures and binding affinity of eight OppA-peptide complexes. Protein Sci (1999) 0.94
A vascular risk factor index in relation to mortality and incident dementia. Eur J Neurol (2006) 0.94
Investigating the high affinity and low sequence specificity of calmodulin binding to its targets. J Mol Biol (1994) 0.93
Outcomes of incident mild cognitive impairment in relation to case definition. J Neurol Neurosurg Psychiatry (2005) 0.93
Characterising the geometric diversity of functional groups in chemical databases. J Comput Aided Mol Des (1995) 0.92
Promoting access to innovation for frail old persons. IAGG (International Association of Gerontology and Geriatrics), WHO (World Health Organization) and SFGG (Société Française de Gériatrie et de Gérontologie) Workshop--Athens January 20-21, 2012. J Nutr Health Aging (2013) 0.92
Conformational change in the activation of lipase: an analysis in terms of low-frequency normal modes. Protein Sci (1998) 0.92
Qualitative analysis of the clinician interview-based impression of change (Plus): methodological issues and implications for clinical research. Int Psychogeriatr (2000) 0.92
Structural aspects of agonism and antagonism in the oestrogen receptor. Biochem Soc Trans (2000) 0.91
Gait and posture impairment, parkinsonism and cognitive decline in older people. J Neural Transm (Vienna) (2007) 0.91
Validity and reliability of the Medical Outcomes Study Short Form-20 questionnaire as a measure of quality of life in elderly people living at home. Age Ageing (1999) 0.90
Domain motions in dihydrofolate reductase: a molecular dynamics study. J Mol Biol (1997) 0.90
Modeling of the three-dimensional structure of the human melanocortin 1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide. J Mol Graph Model (1997) 0.89